Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$102,342,324
+$51,951,625 QoQ
Shares Held
1,201,342
+57.1% QoQ
Ownership
0.864%
of shares outstanding
% of Portfolio
2.84%
of 13F equity value
Holder Rank
#27
of 477 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Jun 30, 2026CallValue
$130,340,700
CallShares
1,530,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026ARMISTICE CAPITAL, LLC holds $1,506,954,940 across 50 Biotechnology names. CYTK ranks #2 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
288,000 | $154,641,600 | |
| 2 | CYTK |
Cytokinetics Inc
This page
|
1,201,342 | $102,342,324 | |
| 3 | INCY |
Incyte Corp
|
900,005 | $102,024,566 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
1,572,539 | $89,335,940 | |
| 5 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,400,000 | $89,064,000 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
1,071,395 | $87,393,690 | |
| 7 | DYN |
Dyne Therapeutics, Inc.
|
3,087,226 | $68,567,289 | |
| 8 | IMVT |
Immunovant, Inc.
|
1,736,000 | $66,888,080 |
All Filings in CYTK
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $130,340,700 | 1,530,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $102,342,324 | 1,201,342 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $50,390,699 | 764,538 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $112,047,000 | 1,700,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $13,182,000 | 200,000 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $95,310,000 | 1,500,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $63,080,351 | 992,766 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $52,212,000 | 950,000 | Call | Sole | 2025-11-17 | |
| 2025-09-30 | $65,779,865 | 1,196,868 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $43,360,010 | 1,312,349 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $44,273,600 | 1,340,000 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $41,130,044 | 1,023,390 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $108,513,000 | 2,700,000 | Call | Sole | 2025-05-15 | |
| 2024-12-31 | $28,694,400 | 610,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $61,716,480 | 1,312,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $100,139,160 | 1,896,575 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $116,160,000 | 2,200,000 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $111,935,392 | 2,065,991 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $54,180,000 | 1,000,000 | Call | Sole | 2024-08-14 | |
| 2024-03-31 | $49,077,000 | 700,000 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $106,965,985 | 1,525,688 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||